Aurobindo Pharma informs about disclosure

17 Mar 2020 Evaluate

Aurobindo Pharma has informed that the exchange has received disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 17, 2020 for K Nityananda Reddy.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1193.70 -23.75 (-1.95%)
08-Dec-2025 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.90
Dr. Reddys Lab 1269.80
Cipla 1510.10
Zydus Lifesciences 929.00
Lupin 2080.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×